Jonathan Sheldon

Jonathan Sheldon

Director/Board Member at CENTOGENE N.V.

52 year
Health Technology
Consumer Services
Commercial Services

Profile

Jonathan G.
Sheldon
is currently the Director at Acmg Foundation For Genetic & Genomic Medicine, Senior VP-Digital Insights Business Area at QIAGEN NV, and an Independent Member-Supervisory Board at Centogene NV.
He previously held positions as the Director at Drug Information Association, Global Vice President-Healthcare Business at Oracle Corp., and Head-Bioinformatics at Roche Products Ltd.
Sheldon received his undergraduate degree from The University of Manchester in 1992 and his doctorate from the University of Cambridge in 1995.

Jonathan Sheldon active positions

CompaniesPositionStart
QIAGEN N.V. Corporate Officer/Principal 01/01/2018
CENTOGENE N.V. Director/Board Member 10/11/2020
Director/Board Member -
Acmg Foundation For Genetic & Genomic Medicine Director/Board Member -
All active positions of Jonathan Sheldon

Former positions of Jonathan Sheldon

CompaniesPositionEnd
ORACLE CORPORATION Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member -
See the detail of Jonathan Sheldon's experience

Training of Jonathan Sheldon

The University of Manchester Undergraduate Degree
University of Cambridge Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jonathan Sheldon's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
ORACLE CORPORATION

Technology Services

QIAGEN N.V.

Health Technology

CENTOGENE N.V.

Commercial Services

Private companies4

Commercial Services

Health Technology

Health Services

Acmg Foundation For Genetic & Genomic Medicine

Miscellaneous

See company connections
  1. Stock Market
  2. Insiders
  3. Jonathan Sheldon
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW